The global market for Monoamine Oxidase Inhibitor (MAOIs) was valued at US$ 197 million in the year 2024 and is projected to reach a revised size of US$ 318 million by 2031, growing at a CAGR of 7.2% during the forecast period.
MAOIs are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are widely...
The global market for Reversible Inhibitors of Monoamine (RIMA) Antidepressants was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks...
The global market for Humanized Antibody was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 7.9% during the forecast period.
Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are r...
The global market for DNA Bowel Cancer Screening Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is a non-invasive genetic test for bowel cancer which examines the DNA code for 11 genes known to cause an increased risk of bowel cancer. It is performed on a blood sample and if possi...
The global market for Miscellaneous Antimalarials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Misecellaneous antimalarials are drugs effective in the treatment of malaria. Malaria is an infectious disease caused by the bite of an anopheles mosquito infected with certain protozoans. Th...
The global market for IL-6 Inhibitors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
IL-6 Inhibitors, which are now considered as promising treatment for COVID-19, target the IL-6 receptors (IL-6Rs), thereby preventing the binding of IL-6 ligands to IL-6 receptors. Thus, inhibiting the en...
The global market for EGFR-TKI for Advanced NSCLC was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutatio...
The global market for Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein.
The global pharmac...
The global market for Human FGFR3 (Fibroblast growth factor receptor) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
FGFR3, also known as CD333, Is a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and amon...
The global market for CD38 Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tum...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals